Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

André Picard is one of Canada’s top health and public policy observers and commentators. He has been a health reporter and columnist for The Globe and Mail, where he has been a staff writer since 1987. He is also the author of six bestselling books.

André is an eight-time nominee for the National Newspaper Awards, Canada’s top journalism prize, and past winner of the prestigious Michener Award for Meritorious Public Service Journalism.

He was named Canada’s first “Public Health Hero” by the Canadian Public Health Association, as a “Champion of Mental Health” by the Canadian Alliance on Mental Illness and Mental Health, and received the Queen Elizabeth II, Diamond Jubilee Medal, for his dedication to improving healthcare.

André is a graduate of the University of Ottawa and Carleton University and has received honorary doctorates from six universities, including UBC and the University of Toronto.

He is a seasoned communicator who employs a conversational style to reach his audience. He enlivens his research and commentary with personal stories to provide context for his audience, including anecdotes from patients and health professionals on the front lines. Fluently bilingual, André will enlighten and pique a sense of curiosity of audience members from all educational backgrounds. Behind the placid exterior lies an inquisitive, perceptive and industrious scribe for whom the work only begins with the official story.

The University of British Columbia recently announced André Picard as one of the Asper Visiting Professors at the School of Journalism, Writing, and Media for the 2020-2021 academic year, winter session.

In 2020, Picard was awarded the The Owen Adams Award of Honour. This award is the highest CMA award available to a non-physician.

Mr. Picard was awarded the 2021 Sandford Fleming Medal for excellence in science communication by the Royal Canadian Institute for Science. Neglected No More was shortlisted for the first Writers’ Trust Balsillie Prize for Public Policy in 2021, and is currently nominated for the 2021 Donner Award, which recognizes the top public policy book written by a Canadian.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Kim Wieringa has led the Health Information Systems Division as an Assistant Deputy Minister and Chief Information Officer for Alberta Health for the last 6 years. This is Kim’s second term in Health having previously spent 9 years in two other divisions. Kim has also held positions in 2 other ministries, and in the municipal and banking environments.

As an executive leader overseeing a diverse portfolio, Kim’s strengths include leading teams though change, policy and program design, strategy development, garnering information technology, project management, and complex stakeholder relations.

As a strategist, Ms. Dhaliwal is focused on bringing the transformational power of data and technology to bear against complex problems in healthcare. Harjeet spent 20 years with the UK National Health Service, most recently as Deputy Director of Data Services at NHS England. Here she led on building a national data repository, broadly used by the NHS and government to look at Covid trends to monitor the spread of the virus and implement measures to ensure services and support is available to patients.

Harjeet has been involved with the NHS at a local, regional and national level focused on data, informatics and business intelligence to support better decisions and improve patient outcomes. Away from work, Harjeet has two sons and enjoys spending time with family and friends.

Dr. Indra Joshi has a unique portfolio of experience spanning data/AI strategy and implementation, digital health, health equity and global advisory – whilst remaining true to her professional training as an emergency medic. She is currently working across the global health and research portfolio of Palantir Technologies to enable better use of data to impact health and care.

Dr. Joshi created the NHS AI Lab which led to the development and deployment of over 80 AI technologies into UK health and care, whilst determining the right ethical guidance and regulations to protect patients. She is a Founding Member and Clinical Director of One HealthTech – a volunteer network which exists to drive better equality, diversity, inclusion, and accessibility in health innovation.

Dr. Joshi is a former member of the World Health Organization Digital Health Technical Advisory – supporting digital health programs and policy, artificial intelligence, ethics, and governance in the healthcare ecosystem with a focus on digital health. Most importantly, Indra is a mum to two wonderful little munchkins.

Mary has over 20 years of executive experience in the British Columbia health system including her service as the President and CEO of Vancouver Coastal Health (VCH) from 2014-2020 and prior executive positions of Chief Operating Officer and Vice-President Facilities, Real Estate and Process Improvement.

Throughout her career, Mary’s passion has been to transform the public system to ensure sustainability in the face of growing demand and constrained resources. As CEO of VCH, she encouraged a focus on innovation and discoveries to improve patient health, transform health systems, and directly impact health and economic outcomes. Her longstanding interest in virtual care enabled health providers to continue delivering care to patients and clients across VCH from the early days of the COVID-19 pandemic.

In 2019, Glassdoor, one of the world’s largest employee recruitment sites named Mary as one of Canada’s Top 25 CEOs based on employee reviews. She was named as one of Canada’s Most Powerful Women in 2014 and 2015. Over the past year, Mary led the innovation and research agenda at the B.C. Ministry of Health as the Senior Executive in Residence and the lead for the Partnerships and Innovation Division.

Mary is a graduate of the Harvard Business School’s Master’s of Business Administration program and holds a Bachelor’s and Master’s degree in Industrial Engineering from West Virginia University.

Lisa has more than 25 years of experience in academic and healthcare leadership, including more than a decade with the Fraser Health Authority in various clinical director roles. She joined BCIT in 2015 as Associate Dean, Laboratory and Allied Health, and became Dean, School of Health Sciences in 2018. She is responsible for the strategic leadership, and overall operational leadership of the School of Health Sciences that includes Laboratory Sciences and Allied Health, Nursing, Diagnostics, and Medical Imaging, and Specialty Nursing programs. As well, she is providing the overall leadership for the school in the development of the new Health Sciences Centre. In addition to being part of BCIT Leadership Team, a major part of her responsibilities is working with external partners and industry to support the overall economic growth in the province.

Lisa holds an MBA (Executive) from SFU, a Bachelor of Home Economics (Dietetics and Nutrition) from UBC, and a Certificate in Health Care Management from BCIT. Known as a strategic, collaborative, and visionary leader, Lisa is passionate and experienced in leading transformational change. Accomplished in engaging diverse internal and external stakeholders to achieve common goals, Lisa has a strong track record of creating high-performing teams and building trusting relationships.

Christine Sorensen (she/her) is a registered nurse with a clinical background in Public Health and Communicable Disease management. From 2017-2021, Christine was the President of the BC Nurses’ Union representing 48,0000 nurses and allied health members from across BC. Currently, Christine is enrolled at the University of BC where she is completing a Masters’ in Health Leadership in Policy. In addition, she teaches Canadian Health Policy to prelicensure nursing students. Christine is Metis, the mother of two young men and an avid traveller.

Dr. Martin Dawes is a world expert in primary care who combines research and clinical practice with over 30 years of experience. Following the completion of his PhD, he helped develop a Masters program in Evidence Based Health Care. He has directed the UK Centre for Evidence-Based Medicine in Oxford and was the head of family practice at McGill University and the University of British Columbia.

Dr. Kendall Ho’s academic and research interests fall into the domain of technology-enabled knowledge translation (TEKT) – the use of information technologies to accelerate the incorporation of the latest health evidence into routine practice. Specific directions within TEKT include telehealth, information and communication technologies (ICT) and patient safety, ICT and public engagement, and evidence-based policy translation in eHealth.

Drew McArthur retired from TELUS in 2007 as Vice President Corporate Affairs and Chief Compliance Officer. As Chief Compliance Officer, Drew was responsible for legal and regulatory compliance for all of TELUS’ operations, reporting to the Audit Committee of the Board of Directors. The responsibilities of this role included ensuring TELUS had the appropriate controls, policies and measurements in place to be compliant with many areas of law and regulation. Drew played a key role in the privacy community in Canada as a founding member of the Council of Canadian Chief Privacy Officers and a member of the advisory board of the International Association of Privacy Professionals (IAPP). From June 2016 to April 2018, Drew was the Acting Information and Privacy Commissioner for BC, and is now consulting in the area of privacy. He can be contacted at drew.mcarthur@telus.net.

An innovator in the technology and security industry, Jaime Chanagá serves as Field Chief Information Security Officer (CISO) at Fortinet for Latin America and the Caribbean. He is passionate about helping private, public, and social sector organizations to address their most critical security challenges ensuring their business success. In this role, he serves as an expert, speaker, and cybersecurity advisor for organizations in the region.

Jaime brings a strong track record as a trusted advisor for cybersecurity strategies to customers in Latin America and the Caribbean, coupled with deep experience in international markets, establishing global strategic partnerships and leading digital transformation programs.

Chanagá is an expert information security professional with an exceptional +20-year career track record in information security, technology, privacy, audit, IT architecture, regulatory compliance, and IT governance. Throughout his career, he has been privileged to serve and advise some of the world’s most admired organizations in the United States, Canada, Europe, and Latin America.

His writing includes collaboration as a co-author of the book Corporate Security in the Information Age (Aspatore). Jaime is also member of InfraGard, a partnership between the FBI and the private sector. InfraGard includes businesses, academic institutions, state and local law enforcement agencies, and other participants dedicated to sharing information and intelligence to prevent hostile acts against the United States.

Chanagá is a Certified Information Systems Security Professional (CISSP). He is also a graduate of the U.S. Federal Bureau of Investigation’s (FBI) Citizens Academy, is a Fusion Liaison Officer for the US Department of Homeland Security (DHS) North Texas Fusion Center (NTFC) and is a member of the United States Secret Service (USSS) Cyber Fraud Task Force (CFTF). Jaime speaks fluent Spanish, Portuguese, and English.

With 20 years experience at Alberta Health and 25 years experience in the health sector, Quinn currently is the Executive Director of Information Management at Alberta Health. His areas responsibilities include stewardship of the Alberta Health Information Act, privacy and security, and eHealth strategy and governance. During the pandemic, Quinn was involved in a number of pandemic related IT initiatives such as ABTraceTogether, the Alberta Covid Records QR code, and the Alberta Vaccine Booking System. Quinn has a BSc. Computing Science and a Master of Public Health both from the University of Alberta.

Pamela Snively joined TELUS as Chief Data and Trust Officer in October, 2015. She leads the team responsible for data and privacy governance at TELUS. Pamela also serves TELUS’ commitment to integrity through her leadership of a variety of initiatives, including the Anti-bribery & Corruption and Competition Law programs.

Prior to joining TELUS, Pamela managed the consulting arm of Osler’s privacy and data management practices, AccessPrivacy by Osler. As a lawyer and consultant, she provided a broad range of privacy, risk-management and compliance advice in the private, public and health sectors. She assisted organizations in implementing enterprise risk-management programs; advising on privacy and outsourcing governance and accountability programs; designing and implementing records-management programs; drafting policies, procedures and training materials; managing data breaches and other regulatory investigations; and conducting privacy impact or risk assessments.

Pamela formerly held Chief Privacy and Risk Officer roles in large business process outsourcing companies in Canada.

Rich leads Accenture’s Global Health Practice, responsible for a network of strategy, consulting, technology, operations and interactive services. For Accenture Health, Rich is responsible for strategic direction, ecosystem relationships, thought leadership, investments and business expansion. Rich is a recognized industry expert with substantial experience helping clients deliver significant cost improvements, improve productivity, and adapt to new industry requirements. He oversees a team of over 20,000 professionals that operate at the intersection of business and technology by combining real-world experience, business and clinical insights, and innovative technologies to drive better health and economic outcomes. Rich has published numerous papers and as a recognized industry spokesperson, he is often quoted on healthcare issues in various media publications including The Wall Street Journal, Forbes and the New York Times. He is responsible for Accenture’s thought leadership that addresses timely topics and challenges facing the health industry.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

Dr. Alan Low is the Executive Director of Medicines Access Coalition – BC, Primary Care Pharmacist and Pharmacy Lead at BioPro Biologics Pharmacy, a collaborative practice approach, focusing on patient centred care. He is also a Clinical Associate Professor in the Faculty of Pharmaceutical Sciences at UBC and an Instructor and Course Developer with the School of Health Sciences at the Justice Institute of BC (JIBC).

Convinced that pharmacists have much more to offer to the public and the healthcare system, Alan has led the development and implementation of provincial medication management projects in BC and Alberta as well as creating a novel model of community pharmacy practice where interprofessional collaboration is leveraged to improve patient health outcomes.

Within the Faculty of Pharmaceutical Sciences at UBC, Dr. Low is one of the founders of the Faculty based Pharmacists Clinic and helped develop and lead the business case for the Pharmacists Clinic. He is the Course Coordinator for the Pharmacy Practice Management and Leadership Course and Lecturer. In addition, he is also a Board Advisor with the GI Society and sits on the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare projects and clinical pharmaceutical consulting. He has held positions such as Clinical Pharmacist, Clinical Specialist, Pharmacotherapeutic Specialist within teaching hospitals, as well as Manager of Government Affairs and Medical Affairs, Medical Science Liaison, and Senior Health Sciences Advisor in research-based pharmaceutical companies and was the Chief Operating Officer at Network Healthcare. Alan is a Certified Clinical Densitometrist (CCD), coauthored “The Osteoporosis Book, 4th Edition: Bone Health”, has numerous publications in scientific and health journals, newsletters, and is a founding co-editor of the Pharmacy Management in Canada textbook.

Alan has been an active member and past participant on various committees (with the College of Pharmacists of BC, BC Pharmacy Association, Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, GI Society, etc). He has interests in the areas of, rheumatology, osteoporosis, gastroenterology, diabetes, and cardiology. Alan enjoys being involved in projects that improve health knowledge translation, healthcare delivery, medical health education and health outcomes research. Alan’s training includes a Bachelor of Science in Pharmacy, a Hospital Pharmacy Residency at St. Paul’s Hospital, and Doctorate of Pharmacy degree at UBC. He is frequently invited to speak at regional, national and international conferences. He strives to develop solutions to close gaps in health care working together with a variety of people.

John Matheson was Director of Finance for the NHS in Scotland from 2008 until his retiral in 2016 with specific responsibility for health technology and innovation. Prior to that he was the Director of Finance at NHS Lothian. He studied at Heriot Watt and Edinburgh Universities.

John was a Council member of the Chartered Institute of Public Finance and Accountancy for 10 years and became President in 2015. Whilst President he focussed on raising the international profile of the Institute including presenting at a number of international conferences and he chairs a committee developing its global strategy.

Currently John chairs the Audit and Risk Committee and provides strategic advice to Transport Scotland. He is a member of the Doctors and Dentists Review Board. He also acts as a Consultant for Digital Health and Innovation Centre at University of Strathclyde. He was also a visiting Professor at Kwansei Gukain University in Osaka Japan.

He was awarded a CBE in 2015 for services to the NHS in Scotland.

Professor George Crooks is currently the Chief Executive of the Digital Health and Care Institute, Scotland’s national innovation centre for digital health and care. He leads an organisation that is tasked with delivering innovation in digital health and care that will help Scotland’s people to live longer, healthier lives, deliver sustainable health and care services for the future and create economic benefits for Scotland. DHI provides opportunities for Scotland’s public sector, academia and industry to co-design digital solutions to some of the country’s biggest health and care challenges working with patients, service users and their families.

He was previously the Medical Director for NHS 24, the Scottish Ambulance Service and Director of the Scottish Centre for Telehealth & Telecare. George was a General Medical Practitioner for 23 years in Aberdeen latterly combining that role as Director of Primary Care for Grampian. George is on the Board of the European Connected Health Alliance and is a past president of the European Health Telematics Association. He is a Board member of TEC Quality, a UK organisation leading the implementation of quality standards and practices across the assisted living sector in the UK. He was an assessor for the European Commission on programmes involving digital health and care provision and is a member of the WHO roster of experts for digital health. He has been an advisor to several European governments and global organisations including the World Bank on digital health and care. He has been appointed as a Bevan Commissioner for Wales and is an advisor to Innovate UK for its Industrial Grand Challenge programme for Health Ageing. He is also an adjunct Professor of Telehealth at the University of Southern Denmark.

He was awarded an OBE in the Queen’s New Year Honours List 2011 for services to healthcare.

Tara McCarville is Principal Consultant at Brighton Group, a health industries solutions firm. As the former National Health Industries Leader for PwC Canada, Tara was accountable for leading a national practice focused on improving outcomes for government, hospital, healthtech/medtech, home/long term care, and private equity clients. In her role at Brighton, Tara is working with clients in both the public and private sector with crisis management, growth strategy & value creation, operational transformation, talent & leadership support.

Tara is on the Board of WELL Health (TSX: WELL), Starling Minds and is Chair of the Board at ALAViDA.

With a professional background in healthcare, management consulting and telecom, Tara has over 20 years of experience providing senior leadership in the private, public and not for profit sectors. She is an experienced, senior health executive who translates complex strategy to high performing operations, while developing talented and accomplished individuals and teams.

Tara holds a Master of Public Administration (MPA) from the University of Victoria, a Bachelor of Arts, Honours (BAH) from Queen’s University and an International Baccalaureate (IB) from the Lester B. Pearson United World College. She is a Certified Health Executive (CHE) and a Project Management Professional (PMP).

Paul Krzyzanowski, PhD, MBA, is the Medical Director, Precision Medicine for Janssen Canada. In this role, he leads the design & execution of Janssen’s precision medicine diagnostics strategy in Canada. His work involves bringing together diverse internal and external stakeholders with scientific, regulatory, and/or commercial perspectives to collaboratively tackle the challenges facing the adoption of precision medicine testing across the country.

Prior to joining Janssen, Dr. Krzyzanowski was the Director of the Translational Genomics Laboratory at the Ontario Institute for Cancer Research (OICR), the first laboratory in Canada to offer validated whole genome sequencing assays under CAP and IQMH accreditations. At OICR, he led his team to productionize and scale up many genomic assays to support oncology research including clinically reported whole genomes & transcriptomes. He was also an Adjunct Lecturer at the Department of Laboratory Medicine and Pathobiology, at the University of Toronto.

Dr. Krzyzanowski has co-authored over 26 peer-reviewed publications and book chapters and is also the co-inventor of several patents in the field of genomic technologies and bioinformatic gene signature development. He holds a MBA from the Rotman School of Management, University of Toronto, a PhD in Molecular Medicine from the University of Ottawa, a BSc(Honours) from the University of Toronto, and was a CIHR-funded Postdoctoral Fellow at OICR.

Yury Monczak has completed his BSc in Microbiology and Immunology at McGill University, followed by a MSc and PhD in Molecular Biology at University of Montreal. Following a post-doctorate at the National Cancer Institute in Frederick, Maryland, USA, he has worked as a senior researcher at the Institute of Clinical Research in Montreal. In 1994 Yury moved to the Jewish General Hospital in Montreal, where he started a molecular diagnostics laboratory in the Department of Hematology. He became assistant professor at the Faculty of Medicine at McGill University in 2005, and also at the University of Montreal in 2015.

Yury has worked in the field of molecular diagnosis of hematopathologies for over 25 years and has seen the field evolve from Southern and Northern blots to present-day NGS panels and single-molecule sequencing.

From 2013 to 2017, John served in the BC Public Service as Deputy Minister of Technology, Innovation and Citizens’ Services. With 1,300 employees and an annual budget of more than $1 billion, the ministry delivered a broad spectrum of government services and economic development programs.

The ministry was responsible for the government’s cyber security strategy and operations, as well as the privacy and freedom of information files. John continues to have a strong interest in the development of privacy and security practice and policy.

Prior to joining the public service, John held a series of senior executive roles in public and private technology companies. Two of his President and CEO roles were with publicly traded companies regulated by both Canadian and United States securities regulators.

Beyond his public service and corporate work, John has long been active in the not-for-profit sector. He was on the Board of the Digital Identity & Authentication Council of Canada (DIACC) from 2013 to 2017 and as a senior board volunteer with a national health charity from 1994 to 2008.

Dr Fiona Duncan is a family physician at Chaldecott Medical Clinic in Vancouver, where she has practiced since 2002. Graduating with a BA and an MD from UBC, she moved east to Thunder Bay for residency in McMaster’s Rural Family Medicine Program, returning home to Vancouver in 2001.

In addition to her own private practice, Dr. Duncan is a Clinical Assistant Professor in the UBC Department of Family Practice and spent 10 years working with Vancouver Coastal Health on Vancouver’s Downtown Eastside, providing primary care, addictions and hepatitis C treatment. Since 2013, she has been involved in physician leadership and systems change, initially as a board member of the Vancouver Division of Family Practice, then as a member of the General Practice Services Committee, and currently as the Physician Lead for the Vancouver Division of Family Practice.

My name is Sarah Hamilton I am a mother of 3 teens, a wife of 20+ years, an enthusiastic athlete, and an advocate of using technology to achieve better health outcomes. I was employed many years as a sales professional in the high tech industry with a focus in healthcare.

My life was flipped upside down in 2017 when I was diagnosed with a cerebellopontine meningioma(brain tumor). Then an 11 hour craniotomy followed to remove the large tumor that was fully compressing my brain stem.

For about 10 years this tumor grew in my head but in the last 18 months before diagnosis I experienced a multitude of health related issues from the tumor. After surgery it left me with new deficits & challenges with my vision, hearing, balance, Cognitive abilities and a debilitating startle symptom. As a million dollar patient my recovery path now is giving back by blending my unique patient experience with my health technology background, tied in with my enjoyment of public speaking; to help improve health outcomes for all. I have an unique understanding of what it is like to navigate the health system which provides me with important insights on the needs, preferences and values that are important to users of the system. Through the sharing of my health care journey, my advisor role offers valuable insight on what healthcare does well and where we can make improvements. One of my key learns is that I need to advocate for myself in the healthcare system. I am Empowered to be the positive voice of the patient in partnering with healthcare initiatives.

Holly is a PhD level trained ethicist and research consultant. She serves as an ethicist on a US-based IRB and is an Adjunct Professor in the Faculty of Health Sciences at Simon Fraser University. She has worked as a consultant for Health Canada, the Public Health Agency of Canada, and the CIHR Ethics Office and her work has been published in a variety of journals including CMAJ, Trends in Neurosciences, and Cell Stem Cell. Her current Director role at the Provincial Health Services Authority (PHSA) of British Columbia reflects PHSA’s commitment to strengthening its research enterprise in support of its fundamental mandate to conduct world class research as an academic health science organization with an integrated mandate to deliver care, conduct research, and train tomorrow’s providers.

Joerg Schwarz is currently Senior Director for Healthcare Interoperability Solutions and Strategy at Infor with over 25 years of experience in the Healthcare Industry and in the interoperability space specifically. Prior to Infor, Joerg worked as a Director at GE Healthcare and Agfa Healthcare, designing and implementing solutions for medical image- and document- exchange and integrated care. He also worked at Boutique Healthcare firms such as NextGate (EMPI) and Audacious Inquiry (ADT Data Intermediary), and he built and directed a $500M Healthcare & Life Sciences Line of Business at the Fortune 500 company Sun Microsystems until it was acquired by Oracle.

Besides Healthcare IT, his passion is Business Intelligence and Data Analytics. Joerg teaches Business Analytics as a Distinguished Adjunct Professor at Golden Gate University’s Ageno School of Business in San Francisco for over 12 years. He holds a Master of Science degree in Information Systems from the University of San Francisco and a business administration and management degree from the Technical University of Cologne in Germany.

Dianne Balon brings over 35 years of experience in healthcare related industries. Currently serving as the Vice President of the Government Division at Alberta Blue Cross, Dianne lends her unique leadership style and talents to both work and in her community. She does not hesitate to challenge the norm when others are too timid to do so. This coupled with her natural intuition and curiosity has led to groundbreaking initiatives in support of improved health and wellness outcomes for the communities she serves.

Dianne works closely with senior government officials—both provincial and across Canada—and a broad sector of the health industry (including, pharmaceutical & medical) to foster effective working relationships. Focused on delivering quality results coupled with strong leadership not only for her organization but for her community, Dianne is highly engaged as both a Director and Board Chair for various organizations and foundations. Dianne is currently serving as the Chair of the Compassion House Foundation and actively serving as a Board Director for The Royal Alexandra Hospital Foundation, the Edmonton Police Foundation, and Edmonton Health City.

Dianne not only wants to make a positive difference in peoples’ lives, she wants to empower those same people to tackle their challenges with gusto and never accepts anything less than incredible. She looks forward to an engaging dialogue with you.

Jeremy Mickolwin is WELL Health’s VP of Clinic Operations. He oversees the company’s primary care, speciality care and allied care network of clinics across Canada. Jeremy has a passion for technological, innovation and agile, future focused solutions within the healthcare industry. He is responsible for the digitization of patient experiences across WELL’s outpatient medical clinic network which is the largest in Canada. Jeremy has a Master of Health Administration from UBC and has worked in healthcare for 20+ years.

After earning his M.B.A. from Queen’s University, Stephen worked at Procter & Gamble and then at internet consulting firm, Cyberplex, where he worked with clients such as Sony, Chrysler, and Sprint to develop their internet strategies. He then founded and ran AllStarLineup for 12 years working with athletes and entertainers such as Magic Johnson, Pedro Martinez and Pamela Anderson, managing their promotional and business opportunities.

Stephen began work in the healthcare industry as Managing Director of the Mount Sinai Fertility Clinic in 2011, and in 2014 became the Director of Business Development at Mount Sinai Hospital. In 2016 he was named VP of Business Innovation & Development for the Sinai Health System, where he led all profit-generating businesses until 2021.

Stephen returned to the private sector in 2021 targeting two significant areas of interest and growth in global healthcare – he founded Paxana Med, a company focused on the use of psychedelics to treat Traumatic Brain Injuries, and joined Petal Solutions as VP, Business Development where he is responsible for the company’s growth in Canada and the US.

Dr. Pieter R. Cullis, PhD is a professor in the Department of Biochemistry and Molecular Biology at the University of British Columbia, co-founder and co-chair of the Personalized Medicine Initiative, and director of the NanoMedicines Research Group at UBC. He has co-founded numerous companies and organisations, including Lipex Biomembranes Inc., Arbutus Biopharma, Northern Lipids Inc. (now Evonik), Acuitas Therapeutics and Precision NanoSystems, and the Centre for Drug Research and Development, where he was Founding Scientific Director from 2004 – 2010.

Cullis has contributed to fundamental advances in the generation, loading and targeting of lipid nanoparticle (LNP) systems for intravenous delivery of small molecule and macromolecular drugs. This work has contributed to three approved LNP products for the treatment of cancer and its complications and a fourth gene therapy drug to treat an hereditary condition that recently completed a most successful Phase 3 trial. He also works to influence the health care system to introduce personalized medicine based on molecular makeup of the individual and their disease.

Cullis has received numerous awards. He was elected as a Fellow of the Royal Society of Canada in 2004 and received the Journal of Drug Targeting’s Lifetime Achievement Award in 2016.

Chris Eagle trained as a cardiac anesthesiologist and had a successful academic career culminating as Professor Emeritus at the University of Calgary. He has held a number of leadership positions including President and COO of the Calgary Health Region, President and CEO of Alberta Health Services, President and CEO of the Calgary Health Trust. He has served as a Board member on a number of health organizations including the Health Quality Council of Alberta and the Canadian Institute for Health Information. Currently, he is chair of the board of trustees of the Alberta Cancer Foundation, and is an advisor on healthcare matters to the Enoch Cree Nation.

Allie DeLonay is a Data Scientist on the Data Ethics Practice team at SAS. Allie earned her bachelor’s degree in Sociology with a concentration in analysis and research and earned a global health certificate at the University of Wisconsin – Madison. In 2019, she earned her master’s degree in Data Science, also from the University of Wisconsin, which was when she was formally introduced to the area of data ethics.

Prior to working at SAS, she spent 9 years working as a Data Scientist for the Health Innovation Program, a health services research organization at the University of Wisconsin – Madison. Her passion in data ethics led her to not only develop AI systems, but also to evaluate whether the AI systems she helped to develop and deploy in the healthcare system could negatively harm vulnerable populations. It was this passion for data ethics that brought her to SAS.

In her current role within the Data Ethics Practice at SAS, Allie works with research & development teams to brainstorm and implement the responsible and ethical AI features required for SAS to substantiate their claim as a leader in responsible innovation.

Alina is the Co-Founder/Co-President of HelpSeeker Technologies – a social technology and innovation Alberta-based B-Corp, founded in 2018. Her background is as a social scientist with a specialization in systems planning and integration, and as a funder and social policy expert. She’s had the opportunity to work in systems change efforts on homelessness and affordable housing, domestic violence, poverty, mental health, and addictions throughout her career. Alina’s drive and passion for her work are grounded in her lived experience of the social issues she continues to challenge in her professional work. Her most recent interest is in putting new technologies to use in reforming the design and delivery of social safety nets.

Jimmy serves as a program executive on a number of key health accounts spanning government, provider, and with leading health technology and pharmacy providers. Jimmy has worked extensively in the health care and life sciences sectors, spanning hospitals, government, agencies, primary/seniors/rural care, clinical research organizations, and pharmaceutical companies. He specializes in corporate strategy, clinical and health system planning, and growth model business planning. He works with leaders who are focused on improvement and transformation, through business and clinical process innovation, and enabled and powered by analytics, AI, and technology.

He has previously held roles at Schering Plough, GlaxoSmithKline, Deloitte Consulting, and Garrison Health. Additionally, he co-founded and serves on the board of Red Maple Trials Inc., a clinical research organization (CRO) that works with biotechnology and pharmaceutical companies, supporting phases I through IV research programs in specific therapeutic areas. Jimmy is a faculty member in the Health Industry Management Program at the Schulich School of Business, York University, where he teaches graduate students in the areas of new business models and convergence approaches in health care and life sciences. He also serve as a Volunteer Advisor in the MaRS Health Venture Services program.

Dr. Robert Fraser is the President and CEO of Molecular You, a digital health company delivering molecular-level personalized health insights and action plans. Dr. Fraser has been at the forefront of developing the framework and technologies to bring personalized medicine into healthcare practice. He is the co-founder of The Personalized Medicine Initiative (PMI), GenXys Health Care Systems, Personalized Biomarkers Incorporated, Mesentech Corporation and Novobind. Dr. Fraser has led drug discovery and development projects at Sanofi, Xenon, Neuromed and CDRD and has been involved in raising of more than $37M in funding. He completed his Ph.D. in the molecular mechanisms of endocrinology at the University of Alberta and Harvard Medical School and Post-Doctoral Fellowships at Hospital for Sick Children, Toronto and IGBMC, Strasbourg France.

Craig Ivany is a health services executive and laboratory services strategist with over 35 years of experience influencing healthcare. His depth of practice includes a legacy of leadership across Canada, including Hospital Executive Director in rural Newfoundland, Executive Director of Canadian Blood Services’ operations portfolio, VP role with DynaLIFE in Alberta, VP role with Dynacare Laboratories in Ontario, CEO of the Eastern Ontario Regional Laboratory Association, President and CEO of Alberta Public Labs, and is a current and past board member of several not-for-profit organizations in Canadian healthcare. In his current role, as the Chief Provincial Diagnostics Officer with Provincial Health Services Authority (PHSA), Craig is leading the implementation of a new province-wide laboratory medicine service delivery model in collaboration with stakeholders across British Columbia. Craig is a certified health executive, a long-time member of the Canadian College of Health Leaders, holds an ICD.D with the Institute of Corporate Directors and is an Adjunct Professor, Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia.

Tim Murphy has 30 years of senior executive leadership experience in the health care sector. Currently, he is the Vice President, Health at Alberta Innovates. Tim was the inaugural Senior Vice President at the Michael Smith Foundation for Health Research and has 10 years of executive leadership with two comprehensive academic oncology centres in Canada. Tim holds a Master of Health Administration from the University of Toronto (1992), a Master of Business Administration from Queen’s University (2006), and a Certified Professional Accountant (CPA) designation.